Short DAPT Just as Good for High-Bleeding Risk Stenting After MI
For high-bleeding risk patients, a shorter duration of dual antiplatelet therapy (DAPT) appeared just as safe for those getting novel stent after acute myocardial infarction (MI) in the MASTER-DAPT trial. Stopping anticoagulant at 30 days didn’t yield significantly different outcomes whether patients had a prior MI or not, reported Pieter C. Smits, MD, PhD, of […]